CombiMatrix, a CLIA-certified laboratory, is bringing microarray analysis to the underserved problem of recurrent pregnancy loss as well as to prenatal testing. CombiMatrix performs microarray assays ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...

When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

Uniting Latin America Through Research: How Regional Research Can Strengthen Local Policies, Networking, and Outcomes for Patients With Lung Cancer Although there are numerous benefits to identifying ...

It wasn’t all that long ago that we cracked the human genome, and in just a few short years we became used to direct-to-consumer genetic sequencing companies, like Ancestry.com and 23&Me, which could ...

While children are known for their active imaginations, it’s extremely rare for them to have true psychotic symptoms. But two unusual case studies, both of children under seven, prompted a new ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...